Rhythm Pharmaceuticals
RYTM
RYTM
165 hedge funds and large institutions have $2.85B invested in Rhythm Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% less capital invested
Capital invested by funds: $2.95B → $2.85B (-$99.8M)
1% less funds holding
Funds holding: 167 → 165 (-2)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
165
Holding in Top 10
8
Calls
$20.3M
Puts
$11M
Top Buyers
| 1 | +$41.1M | |
| 2 | +$31M | |
| 3 | +$13.4M | |
| 4 |
Morgan Stanley
New York
|
+$12M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$11.1M |
Top Sellers
| 1 | -$41.5M | |
| 2 | -$17.9M | |
| 3 | -$16.8M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$9.95M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$7.33M |